Stella Fabiane
Biographic Data
| ID | 9072428 |
|---|---|
| NAME | Stella Fabiane |
| GIVEN NAMES | Stella |
| FAMILY NAME | Fabiane |
| SIGNATURE | FABIANE S |
| AFFILIATIONS | MRC Clinical Trials Unit at UCL |
| ORCID | 0000-0001-5957-7275 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid
Bedaquiline (B), pretomanid (Pa) and linezolid (L) are key components of new regimens for treating rifampicin-resistant tuberculosis (TB). However, there is limited information on the global prevalence of resistance to these drugs and the impact of resistance on treatment outcomes. Mycobacterium tuberculosis (MTB) phenotypic drug susceptibility and whole-genome sequence (WGS) data, as well as patient profiles from 4 pretomanid-containing trials–S…
No prominent works on this page.
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid
Bedaquiline (B), pretomanid (Pa) and linezolid (L) are key components of new regimens for treating rifampicin-resistant tuberculosis (TB). However, there is limited information on the global prevalence of resistance to these drugs and the impact of resistance on treatment outcomes. Mycobacterium tuberculosis (MTB) phenotypic drug susceptibility and whole-genome sequence (WGS) data, as well as patient profiles from 4 pretomanid-containing trials–S…
Bacteria (1 work) · Bedaquiline (1 work) · Biology (1 work) · Cancer therapeutics and mechanisms (1 work) · Clinical trial (1 work) · Drug resistance (1 work) · Genetics (1 work) · Internal Medicine (1 work) · Linezolid (1 work) · Medicine (1 work)